Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aratana Therapeutics Inc acquires Okapi Sciences NV


Monday, 6 Jan 2014 06:13am EST 

Aratana Therapeutics Inc:Says it has acquired Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases.Says under the terms of the stock purchase agreement for the Okapi Sciences acquisition, Aratana paid to Okapi Sciences' equity holders at the closing approximately euro10.3 million in cash and issued a promissory note for euro11 million with a maturity date of Dec. 31, 2014.Says subject to mandatory prepayment in the event of an equity financing, and agreed to pay an additional euro12 million in cash or shares of common stock calculated in the manner specified in the purchase agreement within 90 days. 

Company Quote

10.69
 --
29 Oct 2014